Patient-reported complications associated with Campylobacter jejuni infection

Epidemiology and Infection

Volumn 138, Issue 7, 2010, Pages 1004-1011

  Schonberg Norio D ^a   Mattila, L ^b   Lauhio, A ^b   Katila, M L ^c   Kaukoranta, S S ^d   Koskela, M ^e   Pajarre, S ^f   Uksila, J ^g   Eerola, E ^h   Sarna, S ⁱ   Rautelin, H ^a,b,j  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^e OULU UNIVERSITY HOSPITAL   (Finland)

^f SATAKUNTA CENTRAL HOSPITAL   (Finland)

^g CENTRAL FINLAND CENTRAL HOSPITAL   (Finland)

^h UNIVERSITY OF TURKU   (Finland)

ⁱ UNIVERSITY OF HELSINKI   (Finland)

^j UPPSALA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

Antimicrobial treatment; Campylobacter jejuni; Diarrhoea; Finland; Musculoskeletal symptoms; Reactive arthritis; Serotypes

Indexed keywords

MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ABDOMINAL PAIN; ACHILLES TENDON; ADOLESCENT; ADULT; AGED; ANKLE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTICLE; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CHILD; CROSS-SECTIONAL STUDY; DISEASE DURATION; ELBOW; ENTHESOPATHY; EYE DISEASE; FECES ANALYSIS; FEMALE; FEVER; FINGER JOINT; FINLAND; FOOT; GENDER; GEOGRAPHY; GROUPS BY AGE; HAND JOINT; HEADACHE; HEART DISEASE; HEEL PAIN; HIP; HOSPITALIZATION; HUMAN; INFANT; JOINT SWELLING; KNEE; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MINIMUM INHIBITORY CONCENTRATION; NAUSEA; NECK PAIN; NEUROPATHY; PARESTHESIA; QUESTIONNAIRE; REACTIVE ARTHRITIS; SEROTYPING; SHOULDER; SKIN MANIFESTATION; STOMACH PAIN; SYNOVITIS; TOE JOINT; TREATMENT DURATION; TREATMENT FAILURE; UROGENITAL TRACT DISEASE; VOMITING; WALKING DIFFICULTY; WRIST;

ADOLESCENT; ADULT; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CHILD; CHILD, PRESCHOOL; DIARRHEA; EYE DISEASES; FEMALE; HEART DISEASES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MUSCULOSKELETAL DISEASES; NEURALGIA; PARESTHESIA; QUESTIONNAIRES; SELF DISCLOSURE; UROLOGIC DISEASES; YOUNG ADULT;

EID: 77953615318     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809991099     Document Type: Article

References (26)

1. Blaser M. Epidemiologic and clinical features of Campylobacter jejuni infections. Journal of Infectious Diseases 1997; 176 (Suppl. 2) : S103-105.
2. Rautelin H, Hä nninen M-L. Campylobacters: the most common bacterial enteropathogens in the Nordic countries. Annals of Medicine 2000; 32: 440-445.
3. Nylen G, et al. The seasonal distribution of Campylobacter infection in nine European countries and New Zealand. Epidemiology and Infection 2002; 128: 383-390.
4. Kovats S, et al. Climate variability and Campylobacter infection : an international study. International Journal of Biometeorology 2005; 49: 207-214.
5. Eberhart-Phillips J, et al. Campylobacteriosis in New Zealand: results of a case-control study. Journal of Epidemiology and Community Health 1997; 51: 686-691.
6. Schö nberg-Norio D et al.. Swimming and Campylobacter infections. Emerging Infectious Diseases 2004; 10: 1474-1477.
7. Blaser M, Engberg J. Clinical aspects of Campylobacter jejuni and Campylobacter coli infections. In: Nachamkin I, Szymanski C, Blaser M, eds. Campylobacter, 3rd edn. Washington, DC: ASM Press, 2008, pp. 99-121.
8. Mattila L, et al. Short-term treatment of traveller's diarrhea with norfloxacin: a double-blind, placebocontrolled study during two seasons. Clinical Infectious Diseases 1993; 17: 779-782.
9. Ternhag A, et al. Meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clinical Infectious Diseases 2007; 44: 696-700.
10. Schö nberg-Norio D et al.. Strain and host characteristics of Campylobacter jejuni infections in Finland. Clinical Microbiology and Infection 2006; 12: 754-760.
11. Feodoroff B, et al. Severe diarrhea caused by highly ciprofloxacin- susceptible Campylobacter isolates. Clinical Microbiology and Infection 2009; 15: 188-192.
12. Pope J, et al. Campylobacter reactive arthritis : a systematic review. Seminars in Arthritis and Rheumatism 2007; 37: 48-55.
13. Tam C, et al. Incidence of Guillain-Barré syndrome among patients with Campylobacter infection : a general practice research database study. Journal of Infectious Diseases 2006; 194: 95-97.
14. Rautelin H, Hä nninen M-L. Comparison of a commercial test for serotyping heat-stable antigens of Campylobacter jejuni with genotyping by pulsed-field gel electrophoresis. Journal of Medical Microbiology 1999; 48: 617-621.
15. Schö nberg-Norio D et al.. Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finnish subjects. Antimicrobial Agents and Chemotherapy 2006; 50: 1986-11088
16. Hannu T, et al. Campylobacter-triggered reactive arthritis : a population-based study. Rheumatology 2002; 41: 312-318.
17. Keat A. Reiter's syndrome and reactive arthritis in perspective. New England Journal of Medicine 1983; 309: 1606-1615.
18. Sö derlin M, et al. Infections preceding early arthritis in southern Sweden: a prospective population-based study. Journal of Rheumatology 2003; 30: 459-464.
19. Leirisalo-Repo M. Reactive arthritis. Scandinavian Journal of Rheumatology 2005; 34: 251-259.
20. Townes J, et al. Reactive arthritis following cultureconfirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study. Annals of the Rheumatic Diseases 2008; 67: 1689-1696.
21. Schiellerup P, Krogfelt K, Locht H. A comparison of self-reported joint symptoms following infection with different enteric pathogens: effect of HLA-B27. Journal of Rheumatology 2008; 53: 480-486.
22. Ahvonen P, Sievers K, Aho K. Arthritis associated with Yersinia enterocolitica infection. Acta Rheumatologica Scandinavica 1969; 15: 232-253.
23. Kosunen T, et al. Arthritis associated with Campylobacter jejuni enteritis. Scandinavian Journal of Rheumatology 1981; 10: 77-80.
24. Locht H, Krogfelt K. Comparison of rheumatological and gastrointestinal symptoms after infection with Campylobacter jejuni/coli and enterotoxigenic Escherichia coli. Annals of the Rheumatic Diseases 2002; 61: 448-452.
25. Gillespie I, et al. Investigating vomiting and/or bloody diarrhoea in Campylobacter jejuni infection. Journal of Medical Microbiology 2006; 55: 741-746.
26. Gallay A, et al. Risk factors for acquiring sporadic Campylobacter infection in France: results from a national case-control study. Journal of Infectious Diseases 2008; 197: 1477-1487.